// App-Quantinova.ai

e15131 : Dynamic testing of positive and negative biomarkers on peripheral blood cells at early stages of immunotherapy predicts response in advanced cancer patients.

Researchers

Presenter

  • Wushuang Du

Principal Investigators

  • Yi Hu

Medical Centers

  • PLA General Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Natural Killer cells

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved